These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 3291250

  • 1. Cyclosporine A and histocompatibility in kidney transplantation.
    Cook DJ, Terasaki PI.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):244-8. PubMed ID: 3291250
    [No Abstract] [Full Text] [Related]

  • 2. Effects of HLA matching in cadaver renal transplants.
    Najarian JS, Migliori RJ, Simmons RL, Ascher NL, Payne WD, Dunn D, Sutherland DE, Fryd DS.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):249-56. PubMed ID: 3291251
    [No Abstract] [Full Text] [Related]

  • 3. Impact of blood transfusions and HLA matching on national kidney transplant programs: the first Swedish-Norwegian Study of cyclosporine.
    Albrechtsen D, Flatmark A, Brynger H, Frödin L, Gäbel H, Groth CG, Lundgren G, Maurer W.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):257-60. PubMed ID: 3291252
    [No Abstract] [Full Text] [Related]

  • 4. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
    Kerman RH, Van Buren CT, Lewis RM, Kahan BD.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
    [No Abstract] [Full Text] [Related]

  • 5. The influence of HLA matching in cardiac allograft recipients in a single center.
    Raffoux C, Mayor V, Cabrol C, Busson M, Hors J, Colombani J.
    Transplant Proc; 1987 Oct; 19(5):3559-60. PubMed ID: 3313858
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y, Roels L, Waer M, Gruwez J, Dendievel J, Michielsen P.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of zero HLA class I and II mismatching in cyclosporine-treated kidney transplant patients.
    Cicciarelli J, Terasaki PI, Mickey MR.
    Transplantation; 1987 May; 43(5):636-40. PubMed ID: 3554654
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictors of outcome in cyclosporine-treated recipients of second renal transplants.
    Merion RM, Campbell DA, Dafoe DC, Rosenberg L, Rocher LL, Turcotte JG.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):194-7. PubMed ID: 3291240
    [No Abstract] [Full Text] [Related]

  • 17. Repeated DR mismatching need not be hazardous to kidney graft survival.
    Salmela K, Eklund B, Höckerstedt K, Isoniemi H, Koskimies S, von Willebrand E, Ahonen J.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):677-8. PubMed ID: 2650219
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.